FMR LLC 13D and 13G filings for Lexicon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-08 09:07 am Purchase | 2025-06-30 | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | FMR LLC | 38,137,535 10.500% | 3,594,338 (+10.41%) | Filing |
| 2025-05-12 10:36 am Sale | 2025-03-31 | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | FMR LLC | 34,543,197 9.600% | -15,323,845 (-30.73%) | Filing |
| 2024-11-12 10:32 am Purchase | 2024-11-08 | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | FMR LLC | 49,867,042 13.794% | 11,179,919 (+28.90%) | Filing |
| 2024-07-10 10:10 am Purchase | 2024-07-09 | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | FMR LLC | 38,687,123 10.702% | 33,018,985 (+582.54%) | Filing |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | LEXICON PHARMACEUTICALS INC CO LXRX | FMR LLC | 5,668,138 3.806% | -2,629,962 (-31.69%) | Filing |